Overview
Patients with cardiac risk factors or implanted pacemakers present unique challenges during extracorporeal shock wave lithotripsy (ESWL). Safe management requires understanding potential cardiovascular effects and device interactions.
Key Points
- Cardiac Risk: Includes coronary artery disease, heart failure, arrhythmias, and presence of pacemakers or defibrillators
- Historical Concerns: Early reports of arrhythmias and device interference during ESWL, largely mitigated by modern protocols
- Current Practice: ESWL can be safely performed with appropriate precautions and monitoring
- Patient Selection: Thorough cardiac evaluation recommended pre-procedure
Clinical Reminder: Coordination with cardiology and device specialists is essential for risk stratification and procedural planning.
Cardiac Safety Profile
Arrhythmia Incidence
While ESWL shock waves can transiently affect cardiac rhythm, modern treatment settings reduce these effects:
- Continuous ECG monitoring during procedure is standard for patients with cardiac risk
- Transient arrhythmias such as premature ventricular contractions (PVCs) are most common
- Serious arrhythmias are rare with modern lithotripters and protocols
Pacemaker and ICD Considerations
- Current evidence supports safety of ESWL in patients with pacemakers if appropriate precautions are taken
- Device interrogation before and after ESWL recommended to ensure normal function
- Use of anti-tachycardia pacing and defibrillation features should be coordinated with cardiology
- Shock wave generator positioning to minimize direct impact on device
- Some manufacturers recommend temporarily disabling tachyarrhythmia detection during procedure
Safety Tip: Multidisciplinary planning improves patient safety and confidence during ESWL treatment.
Risks & Contraindications
Absolute Contraindications
ESWL should NOT be performed in patients with:
- Unstable cardiac conditions including recent myocardial infarction (within 3 months)
- Uncontrolled arrhythmias or decompensated heart failure
- Pacemaker malfunction or device infection
- Severe valvular heart disease not optimized
Relative Contraindications
Require careful assessment and cardiology consultation:
- Stable coronary artery disease with history of angina
- Implanted pacemakers or ICDs without recent interrogation
- History of arrhythmias well controlled on medication
- Patients with implantable devices approaching battery depletion
Potential Complications
- Cardiac Arrhythmias: Usually transient and benign, related to shock wave delivery or anesthesia
- Pacemaker Interference: Rare but potential for oversensing or inappropriate inhibition
- Myocardial Ischemia: Risk related to underlying disease and procedural stress, not ESWL itself
- Hemodynamic Instability: Very rare, requires immediate supportive care
Risk Mitigation Strategies
Optimizing patient safety:
- Pre-procedure device check and cardiovascular assessment
- Continuous ECG and pulse oximetry monitoring during ESWL
- Collaboration with cardiology and electrophysiology teams
- Positioning shock waves away from implanted devices when possible
- Use of modern lithotripters with minimal electromagnetic interference
Management & Monitoring
Pre-Procedure Evaluation
- Comprehensive cardiac history including device type, implantation date, and functional status
- Baseline ECG and device interrogation by electrophysiology specialist
- Optimization of cardiac medications and condition stabilization
- Clearance from cardiology before ESWL treatment
Intra-Procedure Monitoring
- Continuous ECG and pulse oximetry throughout the procedure
- Close clinical observation for signs of arrhythmia or distress
- Readiness to pause or terminate procedure if concerning abnormalities arise
Post-Procedure Care
- Immediate post-ESWL device interrogation to ensure proper function
- Monitoring for delayed arrhythmias or ischemic events
- Follow-up with cardiology and urology teams as indicated
- Patient education on symptoms requiring urgent evaluation (palpitations, chest pain)
Note: Communication and coordination between urology and cardiology teams are key to safe ESWL outcomes in this population.
Treatment Outcomes
Safety and Efficacy
Studies have demonstrated that with appropriate planning and monitoring, ESWL is safe and effective in patients with cardiac devices:
- Low incidence of serious cardiac complications
- No significant impact on pacemaker or ICD function
- Stone-free rates comparable to general population
- Improvement in quality of life and symptom relief
Long-term Considerations
- Regular device follow-up and replacement as needed
- Continued cardiac care to manage underlying disease
- Monitoring for late cardiac events post-ESWL
Clinical Insight: ESWL should not be withheld solely due to presence of pacemaker or cardiac risk when managed appropriately.
Key References
1
Alexander J, Horvath KA, Link MS, et al. The safety of extracorporeal shock wave lithotripsy in patients with cardiac pacemakers. J Urol. 2003;170(3):782-787.
PubMed: 12853520
2
Maisel WH. Pacemaker and ICD shocks during extracorporeal shock wave lithotripsy: myth or reality? Heart Rhythm. 2007;4(11):1542-1544.
PubMed: 17977395
3
Paulus C, Tarnev T, Wendt-Nordahl G, Michel MS, Bach T. Safety of extracorporeal shock wave lithotripsy in patients with cardiac pacemaker or defibrillator. Urol Int. 2016;96(4):434-438.
PubMed: 27032708
4
Schmidt T, Wendt-Nordahl G, Michel MS, Wieland WF, Alken P. Does extracorporeal shock wave lithotripsy interfere with pacemaker function? J Urol. 2000;164(2):413-416.
PubMed: 10842412
5
European Society of Cardiology (ESC) Guidelines on Cardiac Devices. 2021.
ESC Guidelines
Additional Resources:
- American Urological Association (AUA) ESWL Guidelines
- Heart Rhythm Society Consensus Documents on Device Management
